Screen LibraryTargeted radionuclide therapy
Saved in:
| Group Author: | |
|---|---|
| Published: |
Wolters Kluwer Health/Lippincott Williams & Wilkins,
|
| Publisher Address: | Philadelphia |
| Publication Dates: | c2011. |
| Literature type: | Book |
| Language: | English |
| Subjects: | |
| Carrier Form: | xvii, 537 p.: ill. (some col.) ; 29 cm. |
| ISBN: |
9780781796934 0781796938 |
| Index Number: | R730 |
| CLC: |
R730.55 R730.51 |
| Call Number: | R730.55/T185-1 |
| Contents: |
Includes bibliographical references and index. "Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting const |